As Sanger sequencing confirmed the segregation of the FAR2 variant with symptoms in patient 2 (Supplemental Figure 2) and as loss of FAR2 function is not linked to neurological disorder or agammaglobulinemia (33), we excluded it from being causal for these patients. The gene discussed is FAR2; the disease is agammaglobulinemia.